Rengalin tab. d / resorption No. 20

Rengalin is indicated for use in adults and children from 3 years old.

Productive and unproductive cough with influenza and SARS, acute pharyngitis, laryngotracheitis, acute obstructive laryngitis, chronic bronchitis and other infectious-inflammatory and allergic diseases of the upper and lower respiratory tract.

Name ENG

RENGALIN

Clinical and pharmacological group

Antitussive, anti-inflammatory drug with antibronchoconstrictor action

ATX code

Other antitussives

Dosage

6mg + 6mg + 6mg

Structure

1 tablet contains: Active substances: antibodies to bradykinin, affinity purified 0.006 g

antibodies to histamine affinity purified 0.006 g

antibodies to morphine, affinity purified 0.006 g

Excipients: isomalt

saccharin sodium

sodium cyclamate

citric acid anhydrous

magnesium stearate

Indications

Acute and chronic respiratory diseases, accompanied by cough and bronchospasm.

Productive and unproductive cough with influenza and SARS, acute pharyngitis, laryngotracheitis, acute obstructive laryngitis, chronic bronchitis and other infectious-inflammatory and allergic diseases of the upper and lower respiratory tract.

Contraindications

Contraindications

Increased individual sensitivity to drug components.

Rengalin is not recommended for use in children under 3 years of age due to insufficient data on efficacy and safety.

Storage conditions and periods

In a dark place at a temperature not exceeding 25 degrees.

Expiration date: 3 years

INN / Active ingredient

antibodies to histamine affinity purified, antibodies to bradykinin, antibodies to morphine

Specifications

Category

Cough

,

Thinning phlegm

,

Expectorants

Scope of the drug

Respiratory system

Release form

Tablet

Manufacturer country

Russia

Package quantity, pcs

twenty

Minimum age from

3 years old

Way of introduction

Through the mouth

Vacation conditions

Without recipe

Brand name

Materia Medica Holding

The amount of the dosage form in the primary package

10 pieces.

Primary packaging type

Blister

Type of consumer packaging

Pack of cardboard

Pharmaco-therapeutic group

Other antitussives

Anatomical and therapeutic characteristics

R05DB Other antitussives

Dosage form

Lozenges

Expiration date in days

1095

Package weight, g

ten

Mode of application

:

At one time - 1 tablet (keep in the mouth until completely dissolved).

Take 1-2 tablets 3 times a day outside meals.

Depending on the severity of the condition in the first 3 days, the frequency of administration can be increased up to 4-6 times a day.

Dosage (volume) of the substance in the preparation

:

antibodies to bradykinin, affinity purified 0.006 g, antibodies to histamine, affinity purified 0.006 g, antibodies to morphine, affinity purified 0.006 g